arrow
Ş

Ştefan Chiriac

grigore t popa university of medicine & pharmacy
H指数:14
被引数:1,075

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting the Gut Microbiome in Cardiovascular Disease: Current Therapeutic Strategies and Future Perspectives

靶向心血管疾病中的肠道微生物组:当前治疗策略与未来展望

2026-09-210
OA
The Role of Rotational Thromboelastometry in High-Risk-of-Bleeding Endoscopic Procedures in Patients with Decompensated Liver Cirrhosis

旋转血栓弹力图在高风险出血内镜操作中失代偿期肝硬变患者中的作用

2026-04-270
OAAI
Integrated Assessment of Intestinal Barrier Function and Microscopic Inflammation Using Confocal Laser Endomicroscopy for Relapse Prediction in Ulcerative Colitis

使用共聚焦激光显微内镜对肠屏障功能及微观炎症进行综合评估,以预测溃疡性结肠炎复发

2026-03-120
OAAI
Prevalence and Risk Factors for Hepatitis C Virus Infection in Vulnerable Populations in Romania: A Population-based Screening from the LIVE(RO)2 Program

罗马尼亚脆弱人群中丙型肝炎病毒感染患病率及危险因素:LIVE(RO)2计划的一项基于人群的筛查研究

2025-12-010
OA
Reply to Scarlata, G.G.M.; Abenavoli, L. Comment on “Rotaru et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis. Life 2025, 15, 288”

回复 Scarlata, G.G.M.; Abenavoli, L. 对“Rotaru et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis. Life 2025, 15, 288”的评论

2025-08-230
PRE
Role of Spleen Stiffness Measurements with 2D Shear-Wave Elastography for Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease

二维剪切波弹性成像测量脾脏硬度对代偿性晚期慢性肝病患者食管静脉曲张的作用

2025-03-100
OAAI
New Insights on Using Oral Semaglutide versus Dapagliflozin in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

在2型糖尿病和代谢功能障碍相关的脂肪性肝病患者中使用口服Semaglutide与Dapagliflozin的新见解

2024-07-103
OAAI